Results 261 to 270 of about 591,098 (317)
CHCHD10 loss in Alzheimer's disease is associated with mitochondrial dysfunction, epigenomic disruption, and tau pathology. Restoration of CHCHD10 shifts DNA methylation toward a non‐disease state and reduces tau and amyloid pathology, with KATNAL2 acting as a downstream effector.
Teresa M. Thomas +13 more
wiley +1 more source
Mitochondrial dysfunction in Alzheimer's disease: targeting the powerhouse with nanomedicine. [PDF]
Kang C, Zhou X, Li B, Li J.
europepmc +1 more source
Hippocampal CA1 and CA2 dendritic compartment-specific differences in mitochondrial form and function. [PDF]
Alsalman M +6 more
europepmc +1 more source
Redox control at the ER-mitochondria interface in kidney transplantation: MAM-centered stress signaling and translational organoid platforms. [PDF]
Kuang B +8 more
europepmc +1 more source
Mitochondrial Regulation of the NLRP3 Inflammasome in Diabetic Kidney Disease: From Mechanisms to Therapeutic Strategies. [PDF]
Chen X, Wu Z, Yu K, Zhang J, Di H.
europepmc +1 more source
The Role of Mitochondria in Polycystic Kidney Disease. [PDF]
Wang Y, Mao J, Liu F.
europepmc +1 more source
Mitochondria-Associated mRNAs Restore ATP During Oxidative Stress via Cytosolic Translation. [PDF]
Back DB +7 more
europepmc +1 more source

